IPSEY (IPSEY) Stock Price & Analysis
IPSEY (IPSEY) fell 6.59% to USD 45.91 as of September 9, 2026 at 23:32 UTC, according to Nexqual real-time market data.
IPSEY last closed at USD 49.15; the session ranged USD 49.15–49.15 on volume of 100 shares. Market capitalization is $15.16B, with a 52-week range of USD 32.02–51.1 (PNK). Source: Nexqual, September 9, 2026 at 23:32 UTC.
Key Statistics (as of September 9, 2026 at 23:32 UTC)
| Price | USD 45.91 |
|---|---|
| Change | ▼ 6.59% (down) |
| Previous Close | USD 49.15 |
| Open | USD 49.15 |
| Day Range | USD 49.15 – 49.15 |
| 52-Week Range | USD 32.02 – 51.1 |
| Volume | 100 shares |
| Market Cap | $15.16B |
| Exchange | PNK |
Technical Analysis (IPSEY)
Nexqual's technical model rates IPSEY "SELL" based on 2 bullish and 4 bearish signals across 126 daily candles, as of September 9, 2026 at 23:32 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.68 (neutral) |
| vs SMA50 | Below (USD 46.54) |
| MACD | 0.62 (positive) |
Analyst Ratings (IPSEY)
Wall Street analysts rate IPSEY "None", per Nexqual as of September 9, 2026 at 23:32 UTC.
| Consensus Rating | None |
|---|
Earnings (IPSEY)
Source: Nexqual, September 9, 2026 at 23:32 UTC.
Financials & Fundamentals (IPSEY)
| Total Revenue | $4.29B |
|---|---|
| Revenue Growth (YoY) | +18.70% |
| Gross Margin | +81.01% |
| Operating Margin | +28.49% |
| Profit Margin | +11.94% |
| ROE | +11.44% |
| Debt / Equity | 20.44 |
| Current Ratio | 1.97 |
| Total Cash | $1.97B |
| Total Debt | $963.10M |
| Free Cash Flow | $1.03B |
Source: Nexqual, September 9, 2026 at 23:32 UTC.
Financial Health Score (IPSEY)
Nexqual rates IPSEY's overall financial health "Strong" across five dimensions, as of September 9, 2026 at 23:32 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 81%, operating 28% |
| Balance Sheet | Strong — $1.97B cash vs $963M debt, net cash position |
| Cash Flow | Strong — FCF $1.03B, 26% margin |
| Efficiency | Mixed — ROE 11%, ROA 10.3% |
Ownership (IPSEY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 330.28M |
| Float | 119.87M |
Source: Nexqual, September 9, 2026 at 23:32 UTC.
Leadership (IPSEY)
IPSEY is led by David Loew (age 58), MD, CEO & Director, per Nexqual as of September 9, 2026 at 23:32 UTC.
| MD, CEO & Director | David Loew (age 58) |
|---|---|
| Executive VP & CFO | Aymeric Le Chatelier (age 56) |
| Global Vice President of Investor Relations | Henry Wheeler M.Sc. (age 41) |
| Executive VP, Chief Product Officer & Head of GPPS | Mari Scheiffele |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGIOY | Shionogi & Co. Ltd. | USD 9.02 | ▼ 2.49% |
| MKKGY | Merck KGaA | USD 30.83 | ▼ 2.17% |
| UCBJY | UCB S.A. | USD 118.75 | ▼ 2.96% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 5.03 | ▼ 2.71% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 37.8 | ▼ 1.7% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 23:32 UTC. This page is informational and not investment advice.